Phytocannabinoids are the cannabinoids produced by the hemp plant (Cannabis sativa L.). Among them, CBD, THC, CBG, CBN, and CBC interact with the human body through specific mechanisms.
But how do these plant molecules interact with our cells?
The interaction between phytocannabinoids and receptors is based on a structured biological logic, primarily centered around:
• CB1 receptors
• CB2 receptors
• Other non-cannabinoid receptors
• Indirect modulation mechanisms
Let's get into the scientific details.
1. What is a phytocannabinoid?
A phytocannabinoid is a cannabinoid of plant origin.
Unlike endocannabinoids (anandamide, 2-AG) produced by the body, phytocannabinoids come from the plant.
They are synthesized in the glandular trichomes of the female flowers.
Their chemical structure allows them to interact with receptors naturally present in the body.
2. Cannabinoid receptors: the main targets
The two most studied receptors are:
CB1
Primarily located in the brain and central nervous system
CB2
Primarily located in the immune system and peripheral tissues
These receptors belong to the GPCR (G protein-coupled receptor) family.
When a ligand binds to it, it triggers an intracellular cascade.
3. Interaction of THC with receptors
THC has a strong affinity for the CB1 receptor.
It acts as a partial agonist.
This means:
• It binds directly to the active site
• It activates the receptor
• It triggers a measurable cellular response
This activation alters the release of neurotransmitters.
This mechanism is what produces the psychotropic effects.
THC also activates CB2, but with a less central role in subjective effects.
4. Interaction of CBD with receptors
CBD works differently.
It does not have a strong affinity for CB1.
It primarily acts as:
• Negative allosteric modulator of CB1
• Indirect modulator of CB2
An allosteric modulator does not bind to the main site of the receiver.
It changes the receiver's configuration.
This can:
• Reduce the effect of THC
• Adjust receptor sensitivity
• Influence intracellular signaling
Therefore, CBD does not strongly activate CB1.
5. Interaction with other biological receptors
Phytocannabinoids are not limited to CB1 and CB2.
They can interact with:
Serotonergic receptors (5-HT1A)
involved in neurological regulation
TRPV1 receptors
involved in sensory transmission
PPAR receptors
involved in metabolic regulation
Adenosine receptors
involved in cell regulation
This versatility explains the complexity of the system.
6. Agonist, antagonist, modulator: important distinctions
Agonist
directly activates the receptor (example: THC on CB1)
Antagonist
blocks the receptor
Modulator
: Modifies the receptor's response without fully activating it (example: CBD)
These distinctions are fundamental to understanding the differences in effects.
7. Affinity and effectiveness
Two concepts must be distinguished:
Affinity:
The ability of a molecule to bind to a receptor
Efficacy:
Ability to trigger a biological response
THC has a notable affinity and efficacy on CB1.
CBD has a low affinity for CB1, but can influence efficacy via modulation.
8. Intracellular signaling
When the receiver is activated:
• Inhibition of adenylate cyclase
• Decrease in cAMP
• Modulation of ion channels
• Reduction in neurotransmitter release
This mechanism is particularly visible with CB1 activation by THC.
CBD indirectly influences these cascades.
9. Cross-interactions between phytocannabinoids
In a full-spectrum extract:
• CBD
• Traces of THC
• CBG
• CBN
• Terpenes
These molecules can interact simultaneously with different receptors.
This is the theoretical basis of the entourage effect.
10. Role of the CBG and the CBN
CBG
can interact with CB1 and CB2 in a moderate way
CBN
has a lower affinity for CB1 than THC, but a higher affinity for CBD.
Each phytocannabinoid has a distinct interaction profile.
11. Influence of molecular structure
The three-dimensional configuration determines:
• Affinity for the receptor
• Type of activation
• Intensity of response
A slight atomic variation can radically change pharmacological behavior.
12. Peripheral Interaction
CB2 receptors are present in:
• Immune cells
• Peripheral tissues
They can be influenced by several phytocannabinoids.
This interaction does not produce any psychotropic effect.
13. Dynamic regulation
The endocannabinoid system functions in balance.
Excessive activation can lead to:
• Desensitization
• Receptor internalization
CBD, as a modulator, does not cause this phenomenon in a marked way.
14. Why this interaction is central to the CBD market
Understanding these mechanisms helps to explain:
• The difference between CBD and THC
• The legality of CBD
• The absence of a euphoric effect
• The positioning of full-spectrum products
Molecular interaction defines biological reality.
15. Overall Summary
Phytocannabinoids interact with receptors via:
• Direct activation (THC)
• Indirect modulation (CBD)
• Secondary interaction with other receptors
This diversity explains the complexity of the endocannabinoid system.
It demonstrates that a cannabinoid is not defined solely by its plant origin, but by its precise relationship with cellular receptors.
FAQ
Do all phytocannabinoids activate CB1
? No. THC is the main strong activator.
CBD block THC?
It can modulate its action via an allosteric mechanism.
Does CBG act like THC?
No, its interaction is different and less potent.
Encyclopedic perspective
The interaction between phytocannabinoids and receptors forms the molecular basis of the hemp universe.
It connects:
• Structural Chemistry
• Pharmacology
• Neuroscience
• Immunology
It is this precise interaction that explains why two molecules from the same plant can produce radically different biological effects.